中(zhong)國同輻(fu)股(gu)份有(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)是中(zhong)國核工(gong)業(ye)集團有(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)控股(gu)子(zi)公(gong)(gong)(gong)(gong)司(si)(si),于2011年在(zai)原(yuan)中(zhong)國同位素有(you)(you)限公(gong)(gong)(gong)(gong)司(si)(si)基礎上重(zhong)組設(she)立,2018年7月6日在(zai)香(xiang)港聯合交易(yi)所成(cheng)功上市(shi)。公(gong)(gong)(gong)(gong)司(si)(si)總(zong)部(bu)下(xia)設(she)總(zong)工(gong)程師(shi)辦、3個委員會和14個職能部(bu)門(men)。共有(you)(you)二級全資子(zi)公(gong)(gong)(gong)(gong)司(si)(si)9家、控股(gu)公(gong)(gong)(gong)(gong)司(si)(si)9家,分公(gong)(gong)(gong)(gong)司(si)(si)1家;三級子(zi)公(gong)(gong)(gong)(gong)司(si)(si)50家。現有(you)(you)員工(gong)2900多人。
中(zhong)國同(tong)輻(fu)股份(fen)有(you)限公司是(shi)(shi)我國集研發、生產(chan)、銷售、服務(wu)于一體的核(he)(he)(he)技術(shu)應(ying)用(yong)(yong)龍頭企業(ye),業(ye)務(wu)領域涵蓋核(he)(he)(he)醫療健(jian)康和輻(fu)照(zhao)應(ying)用(yong)(yong)兩(liang)大(da)(da)(da)產(chan)業(ye)方向(xiang),包括放(fang)射(she)性藥物、醫學診斷(duan)、核(he)(he)(he)醫療裝備、放(fang)射(she)源、輻(fu)照(zhao)應(ying)用(yong)(yong)、核(he)(he)(he)素制造(zao)、進出口貿易七個業(ye)務(wu)單元。公司是(shi)(shi)我國較大(da)(da)(da)、品種較全的放(fang)射(she)性藥物供(gong)應(ying)商,是(shi)(shi)世(shi)界第三大(da)(da)(da)鈷源供(gong)應(ying)商,是(shi)(shi)中(zhong)國較大(da)(da)(da)的輻(fu)照(zhao)裝置設計、制造(zao)、安裝EPC服務(wu)提供(gong)商。目前,公司正圍繞“做大(da)(da)(da)做強做優核(he)(he)(he)技術(shu)應(ying)用(yong)(yong)產(chan)業(ye)”的發展戰略,以“做大(da)(da)(da)”為要(yao)點,以“投(tou)控(kong)源頭、做強核(he)(he)(he)心、擴(kuo)張應(ying)用(yong)(yong)”為路徑(jing),堅持(chi)“產(chan)業(ye)化(hua)、國際化(hua)”戰略理念,著力打造(zao)世(shi)界先進的核(he)(he)(he)技術(shu)應(ying)用(yong)(yong)產(chan)品和服務(wu)供(gong)應(ying)集團。
標準號 | 標準名稱 | 發布日期 | 實施日期 | 標準詳情 |
GB/T 17568-2019 | γ輻照裝置設計建造和使用規范 | 2020-06-04 | 2021-01-01 | |
GB/T 7465-2015 | 高活度鈷60密封放射源 | 2016-10-09 | 2017-11-01 |